By using a virus having a gene sequence comprising a telomerase promoter andanE1 gene (preferably a sequence comprising E1A gene, IRES sequence and E1Bgene) or byusing an anticancer agent comprising the virus, the virus replicates in cancercells to therebyproduce an efficient anticancer effect.